MedTrace Logo

Local Infiltration Analgesia During Total Knee Arthroplasty

NCT01305733 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2012-05-09

No results posted yet for this study

Summary

The primary objective is to evaluate whether local infiltration analgesia (LIA) will reduce oxycodone consumption during the first 48 postoperative hours in patients undergoing total knee arthroplasty (TKA).

Conditions

Interventions

DRUG

The injectant mixture consists of 150 mg levobupivacaine mixed with 30 mg ketorolac and 0.5 mg adrenaline

The injectant mixture consists of 150 mg levobupivacaine mixed with 30 mg ketorolac and 0.5 mg adrenaline

OTHER

saline injection

saline

Sponsors & Collaborators

  • Coxa, Hospital for Joint Replacement

    lead OTHER

Principal Investigators

  • Antti Eskelinen, M.D., Ph.D · Coxa, Hospital for Joint Replacement

  • Mika Niemeläinen, MD · Coxa, Hospital for Joint Replacement

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-05-31
Completion
2012-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01305733 on ClinicalTrials.gov